Anastrozole quantification in human plasma by high-performance liquid chromatography coupled to photospray tandem mass spectrometry applied to pharmacokinetic studies

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 850, Issue 1-2, 2007, Pages 553-559

  Mendes, Gustavo D ^a,b   Hamamoto, Daniele ^a   Ilha, Jaime ^a,b   Pereira, Alberto dos Santos ^a   De Nucci, Gilberto ^a,b  

^a Galeno Research Unit   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Anastrazole; Healthy volunteer; Pharmacokinetics; Photospray; Plasma

Indexed keywords

ACETONITRILE; DICHLOROMETHANE; ETHERS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHARMACOKINETICS; PLASMA (HUMAN);

ANASTRAZOLE; AROMATASE INHIBITOR; LINEAR CALIBRATION CURVE; PHOTOSPRAY;

DRUG PRODUCTS;

ACETONITRILE; ANASTROZOLE; DEXCHLORPHENIRAMINE; DICHLOROMETHANE; ETHER;

ARTICLE; CALIBRATION; DRUG BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

AROMATASE INHIBITORS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; NITRILES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TRIAZOLES;

EID: 34247254837     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2006.11.044     Document Type: Article

References (13)

1. Baum M. Br. J. Cancer 85 Suppl 2 (2001) 15
2. Buzdar A.U., Robertson J.F.R., Eiermann W., and Nabholtz J.M. Am. Cancer Soc. 95 (2002) 2006
3. Howe H.L., Wingo P.A., and Thum M.J. J. Natl. Cancer Inst. 93 (2001) 824
4. Plourde P.V., Dyroff M., and Dukes M. Breast Cancer Res. Treat. 30 (1994) 103
5. Bock M.J., Bara I., LeDonne N., Martz A., and Dyroff M. J. Chromatogr. B 700 (1997) 131
6. Yuan J., Wang P.Q., Ge S.R., An F.R., Shi A.G., Chen J., and Liang J.Y. Acta Pharmacol. Sin. 22 (2001) 573
7. Duan G., Liang J., and Zuo M. Biomed. Chromatogr. 16 (2002) 400
8. Leinonen A., Kuuranne T., and Kostiainen R. J. Mass Spectrom. 37 (2002) 693
9. Silva L.C., Oliveira L.S.O.B., Mendes G.D., Garcia G., Pereira A.S., and De Nucci. J. Chromatogr. B 832 (2006) 302
10. Shah V.P., Midha K.K., Dighe S., McGlivery I.J., Skelly J.P., Yacobi A., Layloff T., Viswanathan C.T., Cook C.E., McDowall R.D., Pitman K.A., and Spector S. Pharm. Res. 9 (1992) 588
11. Bressole F., Petit M.B., and Audran M. J. Chromatogr. B 686 (1996) 3
12. Cai Y., Kingery D., McConnell O., and Bach II A.C. Rapid Commun. Mass Spectrom. 19 (2005) 1717
13. FDA/CDER, Guidance for Industry - Bioavailability and Bioequivalence Studies for Orally Administered Drug Products - General Considerations, Revision 1, March 2003.